1. Kasuga, Yusuke, Ouda, Ryota, Watanabe, Masashi, Hatakeyama, Shigetsugu, Kobayashi, Koichi S. 2023. FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2218955120. doi:10.1073/pnas.2218955120. https://pubmed.ncbi.nlm.nih.gov/37279268/
2. Dubois, Patrick C A, Trynka, Gosia, Franke, Lude, Wijmenga, Cisca, van Heel, David A. 2010. Multiple common variants for celiac disease influencing immune gene expression. In Nature genetics, 42, 295-302. doi:10.1038/ng.543. https://pubmed.ncbi.nlm.nih.gov/20190752/
3. Su, Chenhe, Lu, Fang, Soldan, Samantha S, Kossenkov, Andrew V, Lieberman, Paul M. 2021. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes. In PLoS pathogens, 17, e1009834. doi:10.1371/journal.ppat.1009834. https://pubmed.ncbi.nlm.nih.gov/34352044/
4. Eike, M C, Skinningsrud, B, Ronninger, M, Undlien, D E, Lie, B A. 2012. CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations. In Genes and immunity, 13, 431-6. doi:10.1038/gene.2012.11. https://pubmed.ncbi.nlm.nih.gov/22513452/
5. Devaiah, Ballachanda N, Singer, Dinah S. 2013. CIITA and Its Dual Roles in MHC Gene Transcription. In Frontiers in immunology, 4, 476. doi:10.3389/fimmu.2013.00476. https://pubmed.ncbi.nlm.nih.gov/24391648/
6. Radosevich, Michael, Jager, Martine, Ono, Santa Jeremy. 2006. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator. In Experimental and molecular pathology, 82, 68-76. doi:. https://pubmed.ncbi.nlm.nih.gov/16650406/
智鼠故事 
